The Associated Press highlighted Fred Hutch’s groundbreaking immunotherapy research, including how our teams are turning certain white blood cells into “living drugs,” in an article published last month. The story then appeared in The New York Times, The Washington Post and other news outlets across the country. Want to learn more about harnessing the immune system to conquer cancer? Don't miss our video.
It’s not too late to join us Aug. 11–13 for the fifth anniversary of Obliteride! Choose between the 25-, 50-, 100-mile or two-day route options. We welcome volunteers too! This is Obliteride. This is year five. This is the time to cure cancer faster. Register now.
Join us Sunday, Oct. 1, for Seattle’s iconic stair climb, Base 2 Space. Experience the unique opportunity of climbing the Space Needle’s 832 steps. All proceeds donated to Fred Hutch take us one step closer to a cure. Create a team, climb solo or volunteer; there’s something for everyone! Register now.
Experience an interactive space that showcases our research, tells our stories, and gives everyone who visits our campus the opportunity to share their own stories and connect with the Hutch. Open weekdays from 8:30 a.m. to 5 p.m. in the Arnold Building lobby. Learn more.
Instead of receiving birthday gifts, create a personalized Fundraise for Fred Hutch page and ask your family, friends and social networks to donate to cancer research. Just imagine … your own virtual birthday party for kicking cancer to the curb! Get started today!
Mountain climber and four-time cancer patient Lynn Lippert and her wife, Sal Jepson, don’t want to see funding crises such as economic downturns and lagging government research funding put future Fred Hutch research at risk. That’s why they created an endowment as a source of permanent support to fund cancer breakthroughs. Read their story.
Fred Hutch is excited to be a part of this year’s American Indian Science and Engineering Society’s National Conference. We will showcase our programs and career opportunities. Learn more.
